AI-Generated Drugs and the Patent Problem: How to Mine Patent Data for Novel NCEs Without Blowing Your IP Position
1. The $2.6 Billion Bottleneck AI Is Supposed to Fix The standard number is $2.6 billion. That is the capitalized […]
The Price Floor Problem: How Rock-Bottom Generic Drug Prices Destroy the Supply Chain That Hospitals Depend On
The cheapest medicines in America are also the most dangerous ones to run out of. Generic sterile injectables — levofloxacin,
Pharmaceutical Patent Litigation and Settlements: The Complete Strategic Playbook
Every blockbuster drug carries two price tags: the $2.6 billion average cost of bringing it to market, and the cost
Pharmaceutical Patent Litigation and Settlements: The Complete Strategic Playbook Read Post »
Pfizer’s Portfolio as a Model for Precision in Pharma Investments
The global biopharmaceutical sector has entered a period of profound structural realignment, characterized by the end of the pandemic-driven liquidity
Pfizer’s Portfolio as a Model for Precision in Pharma Investments Read Post »
AI Patent Strategy: Pharma’s Complete Playbook for the $200 Billion Patent Cliff
The numbers are not speculative. Between 2025 and 2029, branded pharmaceutical revenue will fall from $162.8 billion to $67 billion
AI Patent Strategy: Pharma’s Complete Playbook for the $200 Billion Patent Cliff Read Post »
Rucaparib’s Patent Playbook: How One PARP Inhibitor Built a 2035 Exclusivity Wall
The Economic Logic of Pharmaceutical IP: Why Every Dollar Spent on Patents Is a Bet on Survival Biopharma runs on
Rucaparib’s Patent Playbook: How One PARP Inhibitor Built a 2035 Exclusivity Wall Read Post »
In Silico ADMET Modeling: The 20-Year Machine Learning Roadmap Cutting Drug Attrition and Protecting Pharma’s $2.6B R&D Bets
I. Executive Summary Drug discovery’s core problem has not changed: roughly 95% of candidates that enter clinical trials fail, and
See How Researchers are Using DrugPatentWatch:
DrugPatentWatch has published a list of research papers citing DrugPatentWatch at https://www.drugpatentwatch.com/citations/ Explore the Growing Body of Research Citing DrugPatentWatch
See How Researchers are Using DrugPatentWatch: Read Post »
Generic Drug Utilization: The Complete Analyst’s Guide to IP Strategy, Market Dynamics, and Competitive Intelligence
The Economic Architecture of Generic Drug Markets Generic drugs are not simplified copies. They are pharmaceutical products held to the
